Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer
Breast Cancer, Osteoporosis
About this trial
This is an interventional supportive care trial for Breast Cancer focused on measuring osteoporosis, stage I breast cancer, stage II breast cancer, stage IV breast cancer, stage IIIA breast cancer, stage IIIB breast cancer, stage IIIC breast cancer
Eligibility Criteria
DISEASE CHARACTERISTICS: Histologically confirmed adenocarcinoma of the breast by fine needle aspirate, biopsy (tru-cut, core, stereotactic), lumpectomy, or modified radical mastectomy Stage I-III (any T, any N, M0) Stage IV due solely to supraclavicular node involvement allowed Plan to use adjuvant chemotherapy* with or without adjuvant endocrine therapy* Subsequent adjuvant hormonal therapy with an aromatase inhibitor allowed in women rendered postmenopausal by adjuvant chemotherapy NOTE: *Must be specified prior to study entry Hormone receptor status: Not specified PATIENT CHARACTERISTICS: Age: 40 and over Sex: Female Menopausal status: See Disease Characteristics Premenopausal, defined as actively menstruating or last menstrual period occurred within 6 months prior to study entry Prior hysterectomy without bilateral oophorectomy and estradiol and follicle-stimulating hormone within premenopausal range prior to the initiation of chemotherapy allowed Performance status: Not specified Life expectancy: Not specified Hematopoietic: Not specified Hepatic: Not specified Renal: Not specified Other: Not pregnant or nursing Negative pregnancy test Fertile patients must use effective contraception PRIOR CONCURRENT THERAPY: Biologic therapy: Not specified Chemotherapy: See Disease Characteristics No more than 3 months since prior adjuvant chemotherapy Endocrine therapy: See Disease Characteristics Radiotherapy: Not specified Surgery: See Disease Characteristics See Menopausal status Other: No other concurrent bisphosphonates No concurrent digoxin No concurrent tetracycline Concurrent neoadjuvant therapy allowed Concurrent enrollment on therapeutic adjuvant clinical trials allowed provided the therapeutic trial does not preclude participation in this trial
Sites / Locations
- Arroyo Grande Community Hospital
- Rebecca and John Moores UCSD Cancer Center
- El Camino Hospital
- Naval Medical Center - San Diego
- Veterans Affairs Medical Center - San Diego
- Kent General Hospital at Bayhealth Medical Center
- Beebe Medical Center
- CCOP - Christiana Care Health Services
- St. Francis Hospital
- Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
- Washington Cancer Institute at Washington Hospital Center
- Sibley Memorial Hospital
- Michael & Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital
- Memorial Cancer Institute at Memorial Regional Hospital
- Ella Milbank Foshay Cancer Center at Jupiter Medical Center
- CCOP - Mount Sinai Medical Center
- Cancer Research Network, Incorporated
- Cleveland Clinic Florida - Weston
- St. Joseph Medical Center
- Graham Hospital
- Memorial Hospital
- University of Chicago Cancer Research Center
- Eureka Community Hospital
- Galesburg Clinic
- Galesburg Cottage Hospital
- InterCommunity Cancer Center of Western Illinois
- Mason District Hospital
- Hopedale Medical Complex
- Kewanee Hospital
- La Grange Memorial Hospital
- McDonough District Hospital
- BroMenn Regional Medical Center
- Community Cancer Center
- Advocate Christ Medical Center
- Community Hospital of Ottawa
- Cancer Treatment Center at Pekin Hospital
- Proctor Hospital
- CCOP - Illinois Oncology Research Association
- Oncology/Hematology Associates of Central Illinois, P.C.
- Methodist Medical Center of Illinois
- OSF St. Francis Medical Center
- Illinois Valley Community Hospital
- Perry Memorial Hospital
- St. Margaret's Hospital
- Valley Cancer Center
- Elkhart General Hospital
- Center for Cancer Therapy at LaPorte Hospital and Health Services
- Suniti Medical Corporation
- CCOP - Northern Indiana CR Consortium
- Memorial Hospital of South Bend
- Saint Joseph Regional Medical Center
- Hematology Oncology Associates of the Quad Cities
- Iowa Blood and Cancer Care
- St. Luke's Hospital
- Mercy Regional Cancer Center at Mercy Medical Center
- Central Maine Medical Center
- Maine Center for Cancer Medicine and Blood Disorders - Scarborough
- Greenebaum Cancer Center at University of Maryland Medical Center
- Harry and Jeanette Weinberg Cancer Institute at Franklin Square Hospital Center
- Union Hospital Cancer Center at Union Hospital
- Sturdy Memorial Hospital
- Massachusetts General Hospital Cancer Center
- Brigham and Women's Hospital
- Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
- Faulkner Hospital
- Bethke Cancer Center at Emerson Hospital
- Lowell General Hospital
- Fairview University Medical Center - University Campus
- Saint Luke's Hospital
- CCOP - Kansas City
- Siteman Cancer Center at Barnes-Jewish Hospital
- Missouri Baptist Cancer Center
- Missouri Cancer Care, P. C. - Wentzville
- Methodist Cancer Center at Methodist Hospital - Omaha
- University Medical Center of Southern Nevada
- CCOP - Nevada Cancer Research Foundation
- New Hampshire Oncology-Hematology, PA - Hooksett
- Lakes Region General Hospital
- Elliot Regional Cancer Center
- Oncology Center at St. Joseph Hospital
- Jersey City Medical Center at Liberty Health
- Cancer Institute of New Jersey at the Cooper University Hospital - Voorhees
- Roswell Park Cancer Institute
- Memorial Sloan-Kettering Cancer Center
- Nalitt Cancer Institute at Staten Island University Hospital
- CCOP - Hematology-Oncology Associates of Central New York
- Community General Hospital of Greater Syracuse
- Faxton Regional Cancer Center
- Mission Hospitals - Memorial Campus
- Duke Comprehensive Cancer Center
- Wayne Memorial Hospital, Incorporated
- Pardee Memorial Hospital
- Lenoir Memorial Cancer Center
- Moore Regional Community Hospital Comprehensive Cancer Center
- Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University
- Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital
- Rhode Island Hospital
- Women and Infants Hospital of Rhode Island
- Miriam Hospital at Lifespan
- CCOP - Greenville
- Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
- Southwestern Vermont Regional Cancer Center
- Mountainview Medical
- Fletcher Allen Health Care - University Health Center Campus
- Community Cancer Center at Rutland Regional Medical Center
- Danville Regional Medical Center
- St. Mary's Regional Cancer Center at St. Mary's Medical Center
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Zoledronic acid initial tx
Calcium + Vit D initial Tx
Zoledronic acid + calcium + Vit D for 2 years, followed by Calcium + vit D for 1 year
Calcium + vitamin D for 1 year followed by zoledronic acid + calcium + vit D for 2 years